Quest Laboratories Limited (NSE:QUESTLAB)
India
· Delayed Price · Currency is INR 145.35
+6.90 (4.98%)
Apr 29, 2026, 3:14 PM IST
Quest Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Operating Revenue | 1,259 | 1,040 | 825.63 | 616.41 | 594.84 | 303.63 | Upgrade
|
| Other Revenue | 0 | 0 | - | - | - | - | Upgrade
|
| Revenue | 1,259 | 1,040 | 825.63 | 616.41 | 594.84 | 303.63 | Upgrade
|
| Revenue Growth (YoY) | 61.55% | 25.92% | 33.94% | 3.63% | 95.91% | 15.10% | Upgrade
|
| Cost of Revenue | 1,040 | 806.48 | 537.74 | 419.24 | 446.19 | 245.77 | Upgrade
|
| Gross Profit | 219.67 | 233.18 | 287.89 | 197.17 | 148.65 | 57.86 | Upgrade
|
| Selling, General & Admin | 49.73 | 43.27 | 45.03 | 33.59 | 34.77 | 24.1 | Upgrade
|
| Other Operating Expenses | -34.7 | 13.56 | 87.22 | 83.9 | 48.78 | 18.41 | Upgrade
|
| Operating Expenses | -16.19 | 63.2 | 137.93 | 122.98 | 88.15 | 46.45 | Upgrade
|
| Operating Income | 235.86 | 169.98 | 149.96 | 74.19 | 60.5 | 11.41 | Upgrade
|
| Interest Expense | -19.97 | -8.43 | -7.2 | -5.06 | -2.73 | -2.86 | Upgrade
|
| Interest & Investment Income | 25.92 | 25.92 | 2.29 | 0.98 | 0.39 | 0.12 | Upgrade
|
| Other Non Operating Income (Expenses) | 26.55 | -0.63 | -0.59 | -0.32 | -0.23 | -0.21 | Upgrade
|
| EBT Excluding Unusual Items | 268.35 | 186.84 | 144.46 | 69.78 | 57.93 | 8.46 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.04 | -0.26 | 0.02 | Upgrade
|
| Pretax Income | 268.35 | 186.84 | 144.46 | 69.82 | 57.67 | 8.48 | Upgrade
|
| Income Tax Expense | 54.46 | 51.18 | 43.52 | 19.37 | 16.62 | 1.93 | Upgrade
|
| Net Income | 213.89 | 135.66 | 100.94 | 50.45 | 41.05 | 6.55 | Upgrade
|
| Net Income to Common | 213.89 | 135.66 | 100.94 | 50.45 | 41.05 | 6.55 | Upgrade
|
| Net Income Growth | 220.71% | 34.40% | 100.08% | 22.90% | 527.01% | 128.74% | Upgrade
|
| Shares Outstanding (Basic) | 22 | 16 | 16 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 16 | 16 | 11 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | 39.97% | - | 51.91% | - | - | - | Upgrade
|
| EPS (Basic) | 9.92 | 8.28 | 6.16 | 4.68 | 3.81 | 0.61 | Upgrade
|
| EPS (Diluted) | 9.92 | 8.28 | 6.16 | 4.68 | 3.81 | 0.61 | Upgrade
|
| EPS Growth | 129.12% | 34.40% | 31.73% | 22.88% | 527.01% | 129.01% | Upgrade
|
| Free Cash Flow | - | -267.97 | 20.73 | 8.66 | 15.24 | 4.75 | Upgrade
|
| Free Cash Flow Per Share | - | -16.35 | 1.26 | 0.80 | 1.41 | 0.44 | Upgrade
|
| Gross Margin | 17.45% | 22.43% | 34.87% | 31.99% | 24.99% | 19.06% | Upgrade
|
| Operating Margin | 18.73% | 16.35% | 18.16% | 12.04% | 10.17% | 3.76% | Upgrade
|
| Profit Margin | 16.99% | 13.05% | 12.23% | 8.18% | 6.90% | 2.16% | Upgrade
|
| Free Cash Flow Margin | - | -25.77% | 2.51% | 1.41% | 2.56% | 1.56% | Upgrade
|
| EBITDA | 242.73 | 176.34 | 155.64 | 79.68 | 65.1 | 15.35 | Upgrade
|
| EBITDA Margin | 19.28% | 16.96% | 18.85% | 12.93% | 10.95% | 5.05% | Upgrade
|
| D&A For EBITDA | 6.87 | 6.36 | 5.68 | 5.5 | 4.6 | 3.94 | Upgrade
|
| EBIT | 235.86 | 169.98 | 149.96 | 74.19 | 60.5 | 11.41 | Upgrade
|
| EBIT Margin | 18.73% | 16.35% | 18.16% | 12.04% | 10.17% | 3.76% | Upgrade
|
| Effective Tax Rate | 20.29% | 27.39% | 30.13% | 27.74% | 28.82% | 22.79% | Upgrade
|
| Revenue as Reported | 1,329 | 1,082 | 827.92 | 618.66 | 595.42 | 304.13 | Upgrade
|
| Advertising Expenses | - | 0.44 | 0.18 | 0.04 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.